6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

1963 trials found

diseases per page:

Showing 1 to 10 of 1,963 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05669170 (ClinicalTrials.gov)	January 2024	16/12/2022	Methylphenidate for Apathy in Veterans With Parkinson's Disease	Evaluating Safety and Potential Benefit of Methylphenidate as a Symptomatic Treatment for Apathy in ...	Parkinson Disease;Apathy	Behavioral: Psychosocial intervention;Drug: Methylphenidate	Ralph H. Johnson VA Medical Center	NULL	Not yet recruiting	40 Years	N/A	All	60	Phase 2	NULL
2	NCT05721911 (ClinicalTrials.gov)	June 2023	30/1/2023	Implementing a National Biobank of PD With WGS and Functional Assessment of Polygenic Inheritance by ...	Implementing a National Biobank of Genetic, Sporadic and Prodromic Parkinson's Disease With Whole Ge ...	Parkinson Disease;REM Sleep Behavior Disorder	Genetic: whole genome sequencing	Neuromed IRCCS	NULL	Not yet recruiting	18 Years	N/A	All	230		Italy
3	NCT05709301 (ClinicalTrials.gov)	April 1, 2023	11/1/2023	Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's ...	Multicenter, Randomized, Double-blinded, Placebo-controlled Clinical Trial of Donepezil for the Trea ...	Parkinson Disease;Mild Cognitive Impairment	Drug: Donepezil Hydrochloride;Drug: Placebo	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	NULL	Not yet recruiting	50 Years	80 Years	All	120	Phase 2	NULL
4	NCT05634876 (ClinicalTrials.gov)	April 2023	23/11/2022	UB-312 in Patients With Synucleinopathies	A Phase 1b Clinical Trial of UB-312 in Patients With Synucleinopathies	Multiple System Atrophy;Parkinson Disease	Biological: UB-312 Injection;Biological: Placebo Injection	NYU Langone Health	NULL	Not yet recruiting	40 Years	75 Years	All	8	Phase 1/Phase 2	United States
5	NCT05636852 (ClinicalTrials.gov)	March 31, 2023	1/11/2022	Altropane Dose for Imaging Patients With Suspected Parkinson's Disease	An Open-label Multicenter Phase 2 Dose-evaluation Study of Altropane (123I) Injection for Striatal D ...	Parkinson Disease;Movement Disorders	Drug: Altropane (123I) Injection	GE Healthcare	Labcorp Drug Development Inc	Not yet recruiting	18 Years	N/A	All	30	Phase 2	NULL
6	NCT05094011 (ClinicalTrials.gov)	March 1, 2023	20/7/2021	Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects Wit ...	A Phase I Open-Label Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of Aut ...	Idiopathic Parkinson's Disease	Biological: Aadipose-Derived Mesenchymal Stem Cells	Taiwan Mitochondrion Applied Technology Co., Ltd.	NULL	Not yet recruiting	45 Years	70 Years	All	9	Phase 1	NULL
7	NCT05766813 (ClinicalTrials.gov)	March 2023	24/2/2023	Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkin ...	A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety o ...	Parkinson Disease	Drug: Lenrispodun;Drug: Placebo	Intra-Cellular Therapies, Inc.	NULL	Recruiting	40 Years	80 Years	All	132	Phase 2	United States
8	NCT05699694 (ClinicalTrials.gov)	January 5, 2023	11/1/2023	Clinical Study on the Efficacy of Natural Stem Cell Mobilizers on Parkinson Disease	Open-labeled Pilot Study on the Efficacy of a New Food Supplement Composed of Natural Stem Cell Mobi ...	Parkinson Disease	Dietary Supplement: StemRegen product	Sociedad Española de Medicina Regenerativa y Terapia Celular	NULL	Recruiting	21 Years	90 Years	All	40	N/A	Spain
9	NCT05611372 (ClinicalTrials.gov)	January 1, 2023	6/11/2022	Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease	Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease	REM Sleep Behavior Disorder;Parkinson Disease;Synucleinopathies	Drug: Rasagiline	Second Affiliated Hospital, School of Medicine, Zhejiang University	Beijing Tiantan Hospital;Xinhua Hospital, Shanghai Jiao Tong University School of Medicine;Jiangsu P ...	Not yet recruiting	30 Years	75 Years	All	732	Phase 2/Phase 3	NULL
10	NCT05469997 (ClinicalTrials.gov)	January 2023	15/6/2022	Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome	Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome	Parkinson Disease	Behavioral: Mediterranean-Ketogenic Diet;Dietary Supplement: Mediterranean diet supplemented with me ...	University of British Columbia	Weston Family Foundation	Not yet recruiting	45 Years	85 Years	All	50	N/A	NULL

First Previous1 2 3 4 5…197Next Last